Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Wujia Yizhi granules vs donepezil in mild-to-moderate Alzheimer's disease
CTR20191129Phase 2Completed
- Sponsor
- Sichuan Jishengtang Pharmaceutical Co., Ltd.
- Start
- Mar 2020
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Wujia Yizhi Granules in Alzheimer's disease (AD), sponsored by Sichuan Jishengtang Pharmaceutical Co., Ltd.. Started Mar 2020; status: completed.
02
Drugs
Wujia Yizhi Granules
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on CTR20191129.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20191129.